Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
SailPoint, Inc., a leader in enterprise identity security, will host a webcast on October 14, 2026, to recap key product introductions and platform capabilities unveiled at its Navigate annual identity security conference. The webcast aims to provide financial analysts and investors with detailed insights into SailPoint's latest advancements in AI-…
Filana Therapeutics announced the FDA has lifted the clinical hold on simufilam, allowing the company to proceed with a Phase 2a study targeting Tuberous Sclerosis Complex-related epilepsy. Patient screening is expected to begin in early 2027. The 16-week trial will assess safety, tolerability, and efficacy in seizure reduction in 40 patients, supp…
Host Digital Inc., a U.S.-based digital infrastructure company specializing in AI and high-performance computing data centers, has begun trading on the NYSE American under ticker HOST. The company completed a merger to acquire its initial Site I data center and signed an agreement granting preferential rights to acquire additional sites from its Sp…
Lantheus Holdings, Inc. announced that the FDA has granted final approval for BRAVNETSA™ (lutetium Lu 177 dotatate), establishing it as the only radiopharmaceutical deemed bioequivalent and therapeutically equivalent to LUTATHERA® for treating somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Approval via the A…
Lianhe Sowell International Group Ltd., a Nasdaq-listed provider of industrial machine vision and automation solutions, has signed a strategic cooperation agreement with Kumquat Technology Co., a Chery Group subsidiary operating 1,000 4S stores across China. This partnership aims to promote intelligent equipment solutions for 24 automotive aftermar…
Genius Group Limited (NYSE American: GNS) is hosting its second annual Genius Future Summit on November 5-6, 2026, at Genius City in Bali. The event will showcase leading futurists like Dr. Michio Kaku and Peter Diamandis, discuss key future trends in AI, blockchain, and community, and launch new projects including the Genius Awards and Genius City…
Algorhythm Holdings, Inc. (NASDAQ: RIME) announced its strategic priorities focusing on building recurring profitable revenue through its AI-driven logistics segment SemiCab and renewable energy developer Azure Energy. Management plans to reduce SemiCab's operating losses and pursue capital-efficient partnerships, while leveraging Azure's $10M+ con…
AgEagle Aerial Systems Inc., trading as EagleNXT (NYSE: UAVS), announced that its Allen, Texas headquarters is now shipping domestically-produced eBee VISION ISR drones and the newly released MicaSense RedEdge-MX multispectral sensors. The company recently fulfilled a key order delivering nine eBee VISION kits to the U.S. Army's National Training C…
Rhythm Pharmaceuticals announced Health Canada’s approval of IMCIVREE® (setmelanotide) for managing weight in adult and pediatric patients aged 4 and older with acquired hypothalamic obesity (HO). This indication expansion follows successful Phase 3 trial results showing significant BMI reduction. IMCIVREE is a first-in-class MC4R agonist targeting…
SCYNEXIS, a NASDAQ-listed clinical-stage biotech company focused on rare diseases, announced the appointment of Steven K. Burke, M.D., an experienced industry veteran in chronic kidney disease drug development, to its Board of Directors. His expertise supports the company’s advancement of SCY-770, a promising drug candidate for Autosomal Dominant P…
Clene Inc., a late-stage biopharmaceutical company focused on mitochondrial health therapies for neurodegenerative diseases, announced its participation in the 5th Annual ROTH Healthcare Opportunities Conference and the Lytham Partners Investor Conference Fall Event on September 29-30, 2026. Management will conduct one-on-one investor meetings and …
Adagene announced that China's National Medical Products Administration (NMPA) has approved its IND application for ADG138, a novel double-masked HER2xCD3 bispecific T-cell engager designed with proprietary SAFEbody technology to selectively target HER2-expressing tumors with reduced systemic toxicity. The company plans to initiate a Phase 1 study …
Mixed Martial Arts Group Limited (NYSE American: MMA), operating as MMA.INC, announced the pre-sale for its next cycle of the TrainAlta Warrior Training Program at 27 UFC GYM locations across seven states. This cycle, commencing November 9, 2026, represents an approximate 29% increase in locations over the current cycle, expanding into Tennessee an…
FactSet has acquired BCC Group International, a specialist in cloud-native market data distribution platforms, to enhance its Real-Time Solution Suite. This acquisition aims to provide clients with more flexible, open, and modular market data infrastructure solutions, addressing the evolving needs of trading, AI workflows, and regulatory compliance…
XFLH Capital Corporation, a publicly traded special purpose acquisition company (SPAC), announced it has signed a non-binding letter of intent to pursue a business combination with Renogen Biolab Inc., a Canadian health service provider specializing in molecular capabilities such as DNA services, vector engineering, and protein expression. The comp…
Swvl Holdings Corp announces the launch of a 24/7 shuttle service in Madinah, Saudi Arabia, connecting seven hotels to Al-Masjid an-Nabawi and key city landmarks. This initiative deepens Swvl's presence in the Kingdom of Saudi Arabia, targeting the high-demand pilgrimage transport segment with technology-enabled mass mobility solutions. The move al…
Smith+Nephew announced FDA 510(k) clearance for its LANDMARK Total Knee System, a next-generation knee replacement designed to replicate healthy knee anatomy and support personalized knee arthroplasty. The company has completed first surgical cases and plans a phased commercial launch starting with early adopters and broader availability in 2027.
Marker Therapeutics highlights enhanced manufacturing support for its lead immuno-oncology program MT-601 following the combination of its CDMO partner Cellipont Bioservices with Kincell Bio to form Kincellis Advanced Therapies. This expanded U.S.-based organization offers broader infrastructure and expertise to support late-stage clinical developm…
Enlivex Ltd. announced the termination of a previously agreed securities purchase agreement with the Rain Foundation, under which it planned a private placement of ordinary shares payable in RAIN tokens. The termination means the company will not proceed with the private placement nor seek shareholder approval. Enlivex combines clinical-stage immun…
3 E Network Technology Group Limited announced the development of a comprehensive, multi-megawatt green energy architecture for its AI data center in Finland. Leveraging the Nordic region's renewable energy grid and advanced cooling technologies, this infrastructure aims to support next-generation AI hardware with scalable, efficient, and carbon-ne…
FTI Consulting has appointed Eileen Fargis as Senior Managing Director in its global Power, Renewables & Energy Transition practice. With extensive experience in the energy sector, Ms. Fargis will advise clients on strategic, financial, and operational challenges amid growing electricity demand, regulatory changes, and capital constraints. Her appo…
Beta Bionics announced a partnership with Senseonics to integrate its iLet Bionic Pancreas and mint automated insulin delivery systems with the Eversense 365 continuous glucose monitoring system. The combined system is expected to launch commercially in Q4 2026, offering users broader device choice and improved diabetes management through advanced …
Cerenome, Inc. announced that its subsidiary CNSide Diagnostics has signed an in-network agreement with Blue Cross Blue Shield of Michigan, expanding CNSide® CSF Tumor Cell Enumeration assay coverage to approximately 158 million commercial and Medicare Advantage covered lives. This agreement significantly enhances patient access and supports the co…
Wave Life Sciences Ltd., a clinical-stage biotech focusing on RNA medicines, has appointed Dr. Monika Vnuk as Chief Business Officer. Dr. Vnuk brings extensive experience from Sanofi, Blackstone, and Pfizer and will oversee business development, corporate partnerships, and alliance management to support Wave's pipeline advancement and strategic gro…
CervoMed Inc., a clinical-stage biotech company developing treatments for age-related brain disorders, announced its participation in the upcoming ROTH Healthcare Opportunities Conference. The company will present updates on its lead drug candidate, neflamapimod, currently in Phase 2b and Phase 2a trials targeting degenerative brain diseases such a…
